AR and prostate neuroendocrine neoplasm: The CDX also expresses a neuroendocrine phenotype positive for synaptophysin, chromogranin, NSE, and absence of PSA and AR, and reflects the functional state of neuroendocrine prostate carcinoma in being unresponsive to androgen deprivation.